Home Data Calendar Blog

NVTA

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Common Stock Value 0.030.030.030.030.020.020.020.020.020.020.020.020.010.010.010.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.000.00NANANANANANANA
dei: Entity Common Stock Shares Outstanding NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Weighted Average Number Of Diluted Shares Outstanding 275.60263.84249.91NA237.97232.12228.47NA218.38264.92194.00NA132.48129.0299.63NANANANANANANANANANANANANANANANANANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 275.60263.84249.91NA237.97232.12228.47NA218.38204.11194.00NA132.48129.0299.63NANANANANANANANANANANANANANANANANANANANANANANANA
Earnings Per Share Basic -3.42-0.78-0.77NA-1.27-10.87-0.80NA-0.910.66-0.56NA-0.78-1.29-0.99NANANANANANANANANANANANANANANANANANANANANANANANA
Earnings Per Share Diluted -3.42-0.78-0.77NA-1.27-10.87-0.80NA-0.910.53-0.56NA-0.78-1.29-0.99NANANANANANANANANANANANANANANANANANANANANANANANA
Income Loss From Continuing Operations Per Basic Share NANANA-0.00-0.00-0.00-0.00-0.00-0.000.00-0.00-0.00-0.00-0.00-0.00NANANANANANANANANANANANANANANANANANANANANANANANA
Income Loss From Continuing Operations Per Diluted Share NANANA-0.00-0.00-0.00-0.00-0.00-0.000.00-0.00-0.00-0.00-0.00-0.00NANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Revenue From Contract With Customer Excluding Assessed Tax 121.24120.53117.36122.45133.54136.62123.69126.12114.39116.31103.62100.4368.7346.1964.2566.2856.5153.4840.5545.3637.3737.3127.6725.4018.1514.3410.349.246.285.583.963.162.191.801.230.880.310.300.12
Revenues 121.24120.53117.36122.45133.54136.62123.69126.12114.39116.31103.62100.4368.7346.1964.2566.2856.5153.4840.5545.3637.3737.3127.6725.4018.1514.3410.349.246.285.583.963.162.191.801.230.880.310.300.12
Cost Of Revenue 82.1987.4788.4492.84116.96110.3497.1296.1187.7489.3375.4968.2646.6442.9540.4236.7232.1228.0121.2521.1420.4420.4518.0817.0513.2710.499.338.177.246.485.995.513.953.873.202.361.690.960.61
Costs And Expenses 1101.43346.99292.73217.35423.492656.95336.92340.69307.71-12.30215.99NANANANANANANANA71.2667.4867.3764.1560.2949.1242.4137.6734.1931.1829.6729.2627.4524.6425.9319.83NANANANA
Research And Development Expense 58.3463.8261.9871.5387.18115.15128.24131.7697.51106.4580.3672.1737.8074.9655.6751.2846.9525.3017.9916.5715.7815.7815.3713.6111.5011.3410.0211.7811.4810.7110.6611.3811.1311.848.466.465.565.084.96
General And Administrative Expense 45.6269.9745.2443.2444.9452.8651.2750.4386.8238.308.90242.6127.3130.8423.8222.7421.7321.2713.3214.3413.6712.4411.7813.5611.108.066.756.295.665.645.574.464.124.033.444.493.213.001.90
Selling And Marketing Expense 38.0044.7344.5146.8049.1962.7560.1462.2055.5056.9651.2448.8837.8039.5242.1234.5832.6930.7824.1919.2117.5918.7118.9216.0813.2512.5211.577.956.806.847.046.115.446.194.742.852.391.771.67
Operating Income Loss -980.19-226.46-175.37-94.89-289.95-2520.33-213.23-214.57-193.31128.61-112.36-331.48-80.82-142.08-97.78-79.04-76.98-51.89-36.21-25.90-30.11-30.07-36.48-34.89-30.98-28.07-27.34-24.95-24.91-24.09-25.30-24.29-22.46-24.12-18.61-15.28-12.53-10.52-9.02
Interest Expense 5.856.0211.5014.6014.1414.0213.9814.0314.0713.418.3912.526.315.495.455.352.832.122.112.101.841.791.291.141.131.070.320.120.120.100.080.090.060.040.030.010.010.020.02
Gains Losses On Extinguishment Of Debt 0.230.00-10.82NANANANANANANANANANANANA0.00NANANA-5.27NANANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 26.0030.3629.1934.9960.4157.0846.8248.2925.4547.5658.7756.4221.2051.8529.2828.1228.2914.325.225.145.216.114.394.834.786.333.284.353.011.881.471.640.760.540.540.430.210.190.13
Income Tax Expense Benefit -6.17-0.92-0.96-5.35-1.07-3.56-34.92-7.65-5.85-16.56-6.80-109.500.00-2.60NA-5.80-8.70-3.95NA-2.800.000.00NA4.76-4.76-0.43NANANANANANANANANANANANANA
Net Income Loss -942.11-206.51-192.18-99.82-301.16-2523.46-181.86-205.12-198.18133.79-109.49-234.34-102.90-166.40-98.53-76.91-78.71-48.68-37.68-29.84-31.72-31.67-36.12-40.49-27.40-28.56-26.93-24.85-24.97-24.85-25.59-24.36-22.53-24.26-18.64-15.30-12.62-10.54-9.03
Comprehensive Income Net Of Tax -925.64-197.49-192.21-99.00-300.72-2524.01-182.64-205.15-198.19133.77-109.44-234.54-103.28-167.12-97.22-76.91-78.71-48.68-37.66-29.80-31.66-31.62-36.11-40.61-27.42-28.56-26.96-24.87-24.98-24.84-25.55-24.39-22.52-24.23-18.66-15.30-12.62-10.54-9.03
Net Income Loss Available To Common Stockholders Basic NANANANANA-2523.46NANANA133.79NANANA-166.40NANANANANANANANANANANANANA-24.85-24.97-24.85-25.59-24.36-22.53-24.26-18.64-15.30-12.62-10.54-9.03
Net Income Loss Available To Common Stockholders Diluted NANANANANA-2523.46NANANA140.99NANANA-166.40NANANANANANANANANANANANANANANANANANANANANANANANANA
Goodwill Impairment Loss NANANA0.000.002300.00NANANANANANANANANA0.000.000.000.000.000.000.000.00NANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Assets 535.121523.041691.661954.122026.262290.534767.774919.575071.044995.463873.313430.49913.17969.88790.89781.60790.39502.90476.50282.96284.40239.08208.39211.08213.24139.21152.62130.65101.70121.19139.03156.68175.67194.84218.22128.78NANANA
Liabilities 1618.521723.831728.321852.281867.391904.621923.831941.171964.322341.481497.031454.19496.62505.68464.75401.96386.51161.40160.09121.12105.00100.43106.4389.2887.8472.0470.3231.5830.8528.5024.5218.3014.5712.2011.8610.05NANANA
Liabilities And Stockholders Equity 535.121523.041691.661954.122026.262290.534767.774919.575071.044995.463873.313430.49913.17969.88790.89781.60790.39502.90476.50282.96284.40239.08208.39211.08213.24139.21152.62130.65101.70121.19139.03156.68175.67194.84218.22128.78NANANA
Stockholders Equity -1083.40-200.79-36.66101.84158.87385.902843.932978.403106.722653.992376.291976.29416.55464.19326.13379.64403.88341.50316.41161.84179.40138.65101.96121.79125.3967.1682.3099.0770.8492.69114.51138.38161.10182.65206.36-83.58NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Assets Current 378.40451.23504.27693.13729.68894.251030.611178.811365.561644.00779.74453.93415.10471.12357.43442.40508.53287.92321.49165.44167.33122.5189.2286.6890.9586.21107.39101.8074.9696.75114.72131.31150.52174.07188.22109.64NANANA
Cash And Cash Equivalents At Carrying Value 158.01222.76161.20257.49217.03303.63325.33923.25921.631107.74194.22124.79106.44168.2090.22151.39467.01247.00252.50112.16101.4248.5718.4412.0533.8627.6743.4466.8337.7431.5927.3173.2449.0047.5268.26107.0359.1422.0433.84
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 168.11233.27171.23267.52227.06313.65335.61933.52931.911118.02204.49131.48113.12174.5596.56157.57473.19253.24258.37118.16106.4253.8823.8517.4639.2632.6748.1471.5242.4436.46NA78.07NANANA107.18NANANA
Accounts Receivable Net Current 82.5185.6185.5996.1589.1382.5980.4066.2358.4355.7145.5947.7227.3327.9137.7332.5426.7423.1423.7026.3025.4925.0621.4910.426.142.562.031.15NANANANANANANANANANANA
Inventory Net 21.6320.8119.0730.3929.9049.0743.4633.5230.6329.9830.6632.0314.9011.1013.306.606.008.608.808.30NANANA5.40NANANANANANANANANANANANANANANA
Prepaid Expense And Other Assets Current 19.6919.6620.9119.5024.6835.8332.0433.6934.4028.0931.8920.2026.4921.0825.0918.0314.4816.9816.5713.2612.6612.3112.7611.607.908.288.589.188.2211.4610.854.293.273.153.892.62NANANA
Available For Sale Securities Debt Securities 96.57102.38217.50289.61368.94423.14549.38122.12320.46422.47477.38229.19254.85253.93204.39240.440.300.8028.7113.7328.1337.48NA58.59NANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Property Plant And Equipment Gross 134.73168.32169.32179.30188.97192.78183.94163.02145.53122.17107.9897.4578.8473.6969.0763.8859.8854.9549.9152.4053.3350.7951.9449.8746.0043.1941.8738.2634.0229.8527.8027.4325.7924.5622.6419.18NANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 69.2876.2373.8870.5775.0959.8553.9948.3144.5239.4135.0731.3532.7130.3127.9826.1427.7025.9324.1524.5124.0521.9821.6419.5316.6915.5315.2714.4712.7911.149.998.727.145.734.463.50NANANA
Amortization Of Intangible Assets 25.6027.7028.6028.6029.6030.0020.2017.6015.6013.5012.1011.805.605.703.602.802.201.301.301.201.301.301.301.000.600.150.100.000.000.00NANANANANANANANANA
Property Plant And Equipment Net 65.4592.0995.44108.72113.88132.94129.96114.71101.0082.7672.9166.1046.1343.3841.0937.7532.1829.0225.7627.8929.2928.8230.3130.3429.3127.6626.6023.7921.2318.7117.8118.7118.6518.8318.1815.67NANANA
Goodwill NANANANANANA2283.062283.062283.062060.891925.891863.62211.22211.22177.43126.7899.8576.5650.0950.0947.2347.2246.9746.5842.8413.489.43NANANANANANANANANANANANA
Intangible Assets Net Excluding Goodwill NA873.92981.891012.551041.181107.821167.841187.991168.161057.39994.07981.85187.06192.64163.38125.1799.7457.83NA30.47NANANANANANANANANANANANANANANANANANANA
Finite Lived Intangible Assets Net NA873.92981.891012.551041.181107.821137.85645.61625.77514.65451.68439.46157.07162.66133.3995.1969.7527.8429.1630.4731.7332.9934.2635.5220.106.474.12NANANANANANANANANANANANA
Other Assets Noncurrent 19.5320.5721.9823.1221.5227.5228.6923.5523.7919.3014.8913.197.966.927.636.684.795.106.843.063.461.332.000.580.410.400.370.360.810.861.661.831.651.731.483.31NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Liabilities Current 158.42151.97190.18108.09113.32139.25167.90144.09156.17133.64145.78121.75101.44126.90121.2781.8668.9440.0941.6036.3142.8632.6635.2433.3934.8019.6619.7114.7513.3112.2710.5810.888.469.449.657.62NANANA
Accounts Payable Current 25.1823.0711.9013.9810.7326.7541.7021.1335.4031.2438.9925.2015.5920.0925.9810.328.865.259.877.818.045.207.118.6110.685.124.953.352.203.902.693.502.424.051.122.86NANANA
Other Accrued Liabilities Current 3.273.257.235.4713.2212.5311.2510.7440.0528.6527.9128.8616.6112.6412.6216.3912.6410.459.049.438.723.512.772.893.041.511.911.171.240.851.221.251.451.451.880.74NANANA
Accrued Liabilities Current 84.73107.9585.1374.3983.1293.77108.50106.45104.3188.0594.0486.0677.9999.4988.7964.8153.2527.8025.3526.5624.8222.5726.2622.7422.2712.7113.116.716.354.194.244.253.383.647.103.24NANANA
Contract With Customer Liability Current 4.805.205.704.805.705.207.009.438.265.565.266.381.921.731.461.431.151.071.160.760.87NANA0.31NANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Deferred Income Tax Liabilities Net NA6.207.138.139.1811.3415.8051.7051.3851.0050.5751.5410.2510.2510.250.00NANANANANANANANANANANANANANANANANANANANANANANA
Other Liabilities Noncurrent 0.234.244.334.7812.6719.9229.2737.8056.18460.67769.29841.2660.8649.4317.068.007.800.000.158.969.879.799.7313.4411.5911.2310.527.847.386.925.670.340.340.380.410.40NANANA
Operating Lease Liability Noncurrent 134.94139.63143.74134.39138.17142.51121.85124.37120.47122.8478.1348.3642.3642.1342.7742.1944.4145.6942.63NANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Stockholders Equity -1083.40-200.79-36.66101.84158.87385.902843.932978.403106.722653.992376.291976.29416.55464.19326.13379.64403.88341.50316.41161.84179.40138.65101.96121.79125.3967.1682.3099.0770.8492.69114.51138.38161.10182.65206.36-83.58NANANA
Common Stock Value 0.030.030.030.030.020.020.020.020.020.020.020.020.010.010.010.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.000.00NANANANANANANA
Additional Paid In Capital 5061.135018.114984.754931.034889.064815.384749.404701.234624.403973.483829.553337.121542.851487.221182.031138.321085.64944.56870.78678.55666.30593.90525.59520.56483.55397.90384.48374.29321.19318.06315.03313.35311.69310.71310.201.60NANANA
Retained Earnings Accumulated Deficit -6169.94-5227.84-5021.32-4829.14-4729.32-4428.17-1904.71-1722.85-1517.72-1319.55-1453.33-1360.85-1126.51-1023.61-857.20-758.68-681.77-603.07-554.39-516.71-486.87-455.15-423.48-398.60-358.11-330.70-302.15-275.22-250.37-225.40-200.55-174.96-150.60-128.07-103.82-85.18NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax 25.388.91-0.11-0.08-0.90-1.33-0.79-0.010.020.030.050.000.200.571.29-0.010.000.000.01-0.01-0.05-0.11-0.16-0.17NANANANA0.020.030.03-0.01NANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Net Cash Provided By Used In Operating Activities -66.89-54.91-34.40-82.03-128.70-134.69-147.54-175.92-165.05-129.32-89.52-113.58-62.17-60.39-62.36-47.27-36.70-32.73-28.37-15.47-18.08-25.77-32.90-31.25-24.89NANANANANANANANANANANANANANA
Net Cash Provided By Used In Investing Activities 5.12116.0673.88121.8943.80108.97-449.46170.50-20.32-80.70-273.56-312.29-5.67-83.420.80-270.70-17.2025.13-17.5511.186.53-1.8919.957.32-18.88NANANANANANANANANANANANANANA
Net Cash Provided By Used In Financing Activities -3.380.88-135.770.60-1.693.77-0.927.03-0.731123.55436.09444.236.42221.790.552.34273.852.46186.1216.0364.1057.6819.342.1350.37NANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Net Cash Provided By Used In Operating Activities -66.89-54.91-34.40-82.03-128.70-134.69-147.54-175.92-165.05-129.32-89.52-113.58-62.17-60.39-62.36-47.27-36.70-32.73-28.37-15.47-18.08-25.77-32.90-31.25-24.89NANANANANANANANANANANANANANA
Net Income Loss -942.11-206.51-192.18-99.82-301.16-2523.46-181.86-205.12-198.18133.79-109.49-234.34-102.90-166.40-98.53-76.91-78.71-48.68-37.68-29.84-31.72-31.67-36.12-40.49-27.40-28.56-26.93-24.85-24.97-24.85-25.59-24.36-22.53-24.26-18.64-15.30-12.62-10.54-9.03
Depreciation Depletion And Amortization 31.7433.7034.9637.3440.4837.1527.1023.6221.5918.6916.5716.098.468.446.065.074.413.443.293.273.343.493.433.202.441.811.731.621.681.701.551.601.421.281.020.740.610.500.47
Increase Decrease In Accounts Receivable -3.100.02-10.567.026.542.1914.177.801.959.77-2.818.33-0.58-10.115.175.693.60-0.56-2.600.810.453.810.220.160.680.510.600.440.09NANANANANANANANANANA
Increase Decrease In Inventories 0.811.74-11.320.48-19.175.629.942.880.65-0.67-1.37NANA-2.196.62NANANANANANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Payable -0.9611.03-1.943.88-12.92-16.2922.86-11.84-1.20-6.4510.237.07-6.07-3.9013.091.474.04-3.65-0.310.811.88-1.53-1.57-1.81-0.770.191.860.83-0.780.23-0.390.72-1.583.14-1.770.621.53-0.400.33
Deferred Income Tax Expense Benefit -6.17-0.92-0.96-4.01-1.07-3.56-34.92-9.71-5.86-16.56-6.80-109.670.00NANA-5.88-8.70NANA-2.860.00NANANANANANANANANANANANANANANANANANA
Share Based Compensation 26.0030.3629.1934.9960.4157.0846.8248.3125.4347.5658.7756.4221.2051.8529.2828.1228.2914.325.225.145.216.114.394.834.786.333.284.353.011.881.471.640.760.540.540.430.210.190.13
Amortization Of Financing Costs 0.840.0019.86NANANANANANANANANANANANANANANANANA0.25NANANA0.15NANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Net Cash Provided By Used In Investing Activities 5.12116.0673.88121.8943.80108.97-449.46170.50-20.32-80.70-273.56-312.29-5.67-83.420.80-270.70-17.2025.13-17.5511.186.53-1.8919.957.32-18.88NANANANANANANANANANANANANANA
Payments To Acquire Property Plant And Equipment 1.931.421.324.9211.4116.1220.8519.1915.3813.726.438.873.147.023.836.524.716.062.761.711.171.211.872.560.642.131.344.513.312.771.041.161.932.261.124.030.591.200.87

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Net Cash Provided By Used In Financing Activities -3.380.88-135.770.60-1.693.77-0.927.03-0.731123.55436.09444.236.42221.790.552.34273.852.46186.1216.0364.1057.6819.342.1350.37NANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Revenues 121.24120.53117.36122.45133.54136.62123.69126.12114.39116.31103.62100.4368.7346.1964.2566.2856.5153.4840.5545.3637.3737.3127.6725.4018.1514.3410.349.246.285.583.963.162.191.801.230.880.310.300.12
Revenue From Contract With Customer Excluding Assessed Tax 121.24120.53117.36122.45133.54136.62123.69126.12114.39116.31103.62100.4368.7346.1964.2566.2856.5153.4840.5545.3637.3737.3127.6725.4018.1514.3410.349.246.285.583.963.162.191.801.230.880.310.300.12
Change In Estimate Of Revenue Recognition -0.30-1.30-3.00-0.701.101.201.101.504.004.204.301.400.700.901.400.101.202.400.400.701.502.30NANANANANANANANANANANANANANANANANA
Institution 23.4825.0227.6038.3544.2945.2439.63NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Business To Business NANANANA23.5724.5622.3725.1821.8523.8620.0618.009.285.869.90NANANANANANANANANANANANANANANANANANANANANANANANA
Partner NANANANA20.7320.6817.2613.9812.5410.6713.7215.896.134.774.76NANANANANANANANANANANANANANANANANANANANANANANANA
Patient Direct 7.157.917.517.128.7610.4212.1611.2011.0010.528.957.506.384.305.79NANANANANANANANANANANANANANANANANANANANANANANANA
Patient Insurance 90.6187.6082.2576.9880.4880.9771.9075.7669.0171.2560.8959.0346.9331.2743.79NANANANANANANANANANANANANANANANANANANANANANANANA
Institution, Data And Services 9.3412.2012.0410.6512.5711.6411.14NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Institution, Oncology 7.165.817.9921.1723.8624.6920.20NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Institution, Rare Diseases 5.385.486.325.476.086.646.26NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Institution, Womens Health 1.601.541.261.071.772.262.02NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Business To Business, Collaboration And Genome Network NANANANA1.501.201.241.310.943.051.280.910.550.610.72NANANANANANANANANANANANANANANANANANANANANANANANA
Other Business To Business, Diagnostic Tests NANANANA22.0723.3621.1323.8720.9020.8218.7817.098.735.249.19NANANANANANANANANANANANANANANANANANANANANANANANA
Other Business To Business, Test Revenue Centralized NANANANA12.4313.6412.6613.7612.5912.1710.479.588.735.249.19NANANANANANANANANANANANANANANANANANANANANANANANA
Other Business To Business, Test Revenue Decentralized NANANANA9.649.718.4610.118.318.648.31NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Partner, Collaboration And Genome Network NANANANA3.202.242.953.181.771.773.062.710.850.480.45NANANANANANANANANANANANANANANANANANANANANANANANA
Partner, Diagnostic Tests NANANANA17.5218.4414.3110.8010.768.9010.6613.185.294.294.31NANANANANANANANANANANANANANANANANANANANANANANANA
Partner, Test Revenue Centralized NANANANA15.4617.0512.9610.5310.398.6910.2712.345.294.294.31NANANANANANANANANANANANANANANANANANANANANANANANA
Partner, Test Revenue Decentralized NANANANA2.071.391.340.270.370.210.38NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Patient Direct, Diagnostic Tests NANANANA8.7610.4212.1611.2011.0010.528.957.506.384.305.795.234.574.063.743.883.283.582.852.271.760.85NANANANANANANANANANANANANA
Patient Direct, Oncology 1.681.851.711.832.212.863.44NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Patient Direct, Rare Diseases 2.392.562.392.242.582.512.72NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Patient Direct, Test Revenue Centralized NANANANA8.7610.4212.1611.2011.0010.528.957.506.384.305.79NANANANANANANANANANANANANANANANANANANANANANANANA
Patient Direct, Womens Health 3.083.503.413.053.985.056.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Patient Insurance, Diagnostic Tests NANANANA80.4880.9771.9075.7669.0171.2560.8959.0346.9331.2743.7947.1440.5338.4327.7230.8024.3724.2016.9715.5310.3110.12NANANANANANANANANANANANANA
Patient Insurance, Oncology 52.9052.1550.6252.9453.1053.6648.54NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Patient Insurance, Rare Diseases 15.5313.9211.438.438.498.006.60NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Patient Insurance, Test Revenue Centralized NANANANA80.4880.9771.9075.7669.0171.2560.8959.0346.9331.2743.79NANANANANANANANANANANANANANANANANANANANANANANANA
Patient Insurance, Womens Health 22.1821.5320.2115.6118.8919.3116.77NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Collaboration And Genome Network 3.684.594.733.414.703.444.194.502.724.824.343.621.401.091.171.241.011.170.930.810.760.960.620.830.840.74NANANANANANANANANANANANANA
Data And Services 9.3412.2012.0410.6512.5711.6411.14NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Diagnostic Tests 117.56115.94112.62119.04128.84133.18119.50121.62111.68111.5099.2896.8167.3345.1063.0865.0555.5052.3039.6244.5536.6136.3527.0524.5717.3113.59NANANANANANANANANANANANANA
Oncology 61.7459.8060.3175.9479.1781.2072.17NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Rare Diseases 23.3021.9620.1316.1417.1617.1515.58NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Test Revenue Centralized NANANANA117.13122.07109.69111.25102.99102.6490.5988.4667.3345.1063.08NANANANANANANANANANANANANANANANANANANANANANANANA
Test Revenue Decentralized NANANANA11.7111.119.8110.388.698.868.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Womens Health 26.8626.5824.8819.7324.6426.6224.79NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
1.892.292.102.212.102.722.302.161.941.911.541.411.100.801.221.351.160.880.961.051.051.101.010.940.820.860.600.660.510.570.781.030.340.610.120.150.080.080.01
NANANA0.111.542.172.021.891.711.712.80NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
1.400.651.191.313.001.772.151.890.261.691.65NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
US 113.72113.27110.46111.34117.32120.11108.30110.14100.96102.5090.4188.2264.3243.3359.8161.8552.6950.3737.6542.5334.9134.9025.9123.7016.6412.959.217.995.254.602.961.941.600.970.970.600.230.150.10
Rest Of World 4.234.333.607.489.579.8510.958.4213.4413.8113.2110.803.312.063.223.082.672.231.941.781.411.310.760.750.680.530.530.590.520.410.210.020.240.220.130.100.000.010.01
Non Us NANANANANANA8.93NANANA7.22NANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Income Tax Expense Benefit
Balance Sheet
Stockholders Equity
Assets
Inventory Net
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Other Accrued Liabilities Current
Noncurrent Liabilities
Other Liabilities Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
NetCashProvidedByUsedInFinancingActivities
Net Cash Provided By Used In Financing Activities
Shares
Common Stock Shares Issued
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Year Three
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Accumulated Amortization
InventoryNet
Inventory Finished Goods Net Of Reserves

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:MajorCustomers, us-gaap:ProductOrService
(None, 'nvta:DiagnosticTests')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:MajorCustomers, us-gaap:ProductOrService
('nvta:Institution', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:MajorCustomers
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Major Customers
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:BusinessAcquisition
(None,)
Allocated Share Based Compensation Expenseus-gaap: Business Acquisition
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
(None,)
Finite Lived Intangible Assets Netus-gaap: Finite Lived Intangible Assets By Major Class
us-gaap:LongTermDebt
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
(None, 'us-gaap:ConvertibleDebt')
Long Term Debtus-gaap: Debt Instrument, us-gaap: Longterm Debt Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:StockIssuedDuringPeriodValueNewIssues
us-gaap:StatementEquityComponents
(None,)
Stock Issued During Period Value New Issuesus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:MajorCustomers, us-gaap:ProductOrService
(None, 'nvta:DiagnosticTests')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:MajorCustomers, us-gaap:ProductOrService
('nvta:Institution', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:MajorCustomers
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Major Customers